欧洲前列腺癌筛查随机研究(ERSPC)中的癌症检出情况
该研究分析ERSPC试验中55-69岁男性(除法国外)三个筛查周期的癌症检出率,比较低级别与中高级别前列腺癌的检出趋势。结果显示低级别癌检出率持续高于中高级别,高级别癌检出率各中心趋势不一,间隔期癌和非参加者癌增加提示统一筛查方案效果下降,支持个性化筛查策略。
要点
- 低级别前列腺癌检出率在所有中心和筛查周期中均持续高于中高级别癌。
- 高级别癌检出率各中心趋势不同:多数中心第一至第二周期下降、第三周期回升,西班牙则逐周期上升。
- 间隔期癌和非参加者癌增加,提示统一筛查方案效果递减,需个性化筛查并提高参与率。
核心结论
- ERSPC数据显示重复筛查中低级别癌检出率下降,中高级别癌检出率各中心间差异显著。
- 间隔期癌和非参加者癌增加表明统一筛查方案效果递减,支持个性化筛查和改善参与策略。
研究设计与样本
- 分析ERSPC试验中除法国外各中心随机纳入的55-69岁男性。
- 筛查组男性分为曾参加者(至少参加一个筛查周期)和非参加者(未参加特定筛查周期),按年龄组和中心计算三个筛查周期的癌症检出率。
- 二次分析纳入曾参加者和非参加者中的间隔期前列腺癌病例,并纳入对照组发病率数据进行比较。
主要发现
- 基于筛查检出病例,低级别癌的检出率在所有中心和筛查周期中均持续高于中级别和高级别癌。
- 高级别癌检出率趋势各中心不同:多数中心从第一周期到第二周期下降、第三周期回升,西班牙则每个筛查周期均上升。
临床怎么用
- 筛查实践中应关注低级别癌过度检出与高级别癌检出不足并存的现状。
- 统一筛查方案效果有限,可考虑根据年龄、中心差异等因素制定个性化筛查策略。
- 需采取措施维持并提高筛查参与率,以减少非参加者癌和间隔期癌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To provide a comprehensive analysis regarding outcomes of repeated screening and detection of low-grade versus high-grade cancer from the European Randomised Study of Screening for Prostate Cancer (ERSPC). MATERIALS AND METHODS: This study analysed men aged 55-69 years at random across the ERSPC trial centres except France. Men in the screening arm were classified as ever-attenders (who attended at least one screening cycle) or non-attenders (who did not attend a specific screening cycle). Cancer detection rates (CDRs) were calculated by age group and centre across three screening cycles. A secondary analysis incorporated interval prostate cancer (PCa) cases-those diagnosed outside the screening protocol-among both ever-attenders and non-attenders. Incidence data from the control arm were included for comparison. RESULTS: Based on screen-detected cases, CDRs were consistently higher for low-grade than for intermediate- and high-grade cases across all centres and screening cycles. Trends in CDRs for high-grade cases varied by centre: CDRs decreased from the first to the second cycle and increased again during the third cycle in most centres, whereas CDRs increased in Spain with each successive screening cycle. CONCLUSION: The ERSPC data show a decreasing detection rate for low-grade cancer and substantial variation in the detection rate for intermediate- and high-grade cancer between centres across repeated screening rounds. Increasing interval and non-attender cancers indicate diminishing effectiveness of uniform screening schedules. These findings support personalised screening approaches and improved strategies to maintain participation.
引用
- Pasanen N, Talala K, Remmers S, et al. Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC). BJU Int. 2026. PMID: 42400346. doi:10.1111/bju.70380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。